Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD
Emilie L. Vander Haar
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
Kristina Deligiannidis, MD
Jennifer L. Payne, MD
Irritable Bowel Syndrome: Clarifying the Vagaries and Improving Patient Care in Women
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kavita R. Kongara, MD, FACG, FACP
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
The Impact of Early Diagnosis in Improving Patient Outcomes in Endometriosis: Physical and Psychosocial Consequences
Lee P. Shulman, MD, FACMG, FACOG
Linda Bradley, MD
Patient-Centric Tools to Support Shared Decision-Making: Diagnosing and Assessing Endometriosis
Melissa Simon, MD
Pain Points: Weighing the Benefits and Drawbacks of the GnRH Antagonists Throughout the Endometriosis Treatment Journey
Creating a Practice Environment That Enhances Healthcare Equality for All Patients
Clinical Considerations for the Diagnosis of Endometriosis
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
Samantha Denäe
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Alloimmune Thrombocytopenia in the Fetus and Newborn
James B. Bussel, MD
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Kenneth J. Moise Jr., MD
Red Blood Cell Alloimmunization, Pathophysiology, Diagnosis, Treatment, and Prevention
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.